$62.31
-2.02-3.14%
Last update: Nov 10, 4:42 PM
Inspire Medical Systems Inc
INSPNYSE
Inspire Medical Systems fell 29.0% from $90.59 to $64.33, behind the S&P 500's +9.8%. Its worst day was Dec 18 (−19.4%), and its low came May 15 at $40.05.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Inspire Medical Systems shares rose 30.5%, while the S&P 500 rose 1.5%.
+30.5%, the year's best day · S&P 500 +1.5%
Story events cover the past 12 months · Times ET
Inspire Medical Systems closed at its highest level of the year, 58.9% above where the year started.
+5.2% · S&P 500 −0.3%
Inspire Medical Systems shares fell 19.4%, while the S&P 500 rose 0.5%.
−19.4%, the year's worst day, on 7M shares, the year's heaviest volume · S&P 500 +0.5%
Inspire Medical Systems shares fell 16.0%, while the S&P 500 rose 0.5%.
−16.0% · S&P 500 +0.5%
EPS of $1.65 beat the $0.69 estimate on $269.1M revenue (est. $267.3M); FY revenue guidance of $950.0M–$1.0B against the $964.5M consensus.
−12.5% · S&P 500 −1.5%
Inspire Medical Systems shares rose 14.9%, while the S&P 500 fell 0.6%.
+14.9% · S&P 500 −0.6%
EPS of $0.10 beat the $-0.28 estimate on $204.6M revenue (est. $199.8M); FY revenue guidance of $825.0M–$875.0M against the $961.2M consensus.
−12.0% · S&P 500 +0.8%
Inspire Medical Systems closed at its lowest level of the year, 55.8% below where the year started.
−6.1% · S&P 500 −1.2%
EPS of $0.14 beat the $-0.24 estimate on $200.6M revenue (est. $194.7M); FY revenue guidance of $835.0M–$875.0M against the $848.9M consensus.
+22.8% · S&P 500 +1.8%
EPS of $0.14 beat the $0.09 estimate on $206.7M revenue (est. $204.3M); FY revenue guidance of $850.0M–$860.0M against the $853.6M consensus.
−7.9% · S&P 500 +0.3%
Where it ended: a close of $64.33 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 10, 2027 (EPS est. $0.28, revenue est. $203.0M).
Nothing in the past 12 months.
All INSP dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for INSP and SPY from Benzinga historical bars. Not investment advice.
